Nesfatin-1: role as possible new anti-obesity treatment

Authors

  • Carmine Finelli Center of Obesity and Eating Disorders, Stella Maris Mediterraneum Foundation, Chiaromonte, Potenza, Italy
  • Giuseppe Martelli Department of Science, University of Basilicata, Potenza, Viale dell'Ateneo Lucano, 10, 85100, Italy
  • Rocco Rossano Department of Science, University of Basilicata, Potenza, Viale dell'Ateneo Lucano, 10, 85100, Italy
  • Maria Carmela Padula Department of Science, University of Basilicata, Potenza, Viale dell'Ateneo Lucano, 10, 85100, Italy
  • Nicolina La Sala Center of Obesity and Eating Disorders, Stella Maris Mediterraneum Foundation, Chiaromonte, Potenza, Italy
  • Luigi Sommella Unit of Surgery, S. Giovanni Hospital - Lagonegro, Potenza, Italy
  • Giovanni Tarantino National Cancer Institute "Pascale Foundation" - IRCS- 83013 Mercogliano (Av), Italy

Keywords:

nesfatin-1, obesity, drug treatment

Abstract

In this article, we review on the current concepts about Nesfatin-1 as a new anti-obesity treatment and evaluate the existing issues in the context of this knowledge and the available literature. The intent is to enable clinicians to know Nesfatin-1 as a new anti-obesity treatment and make rational decisions based on this perspective as possible clinical application. Future research should seek to clarify whether Nesfatin-1 would be beneficial in the management of obesity.

Published

2014-05-26

How to Cite

Finelli, C., Martelli, G., Rossano, R., Padula, M. C., La Sala, N., Sommella, L., & Tarantino, G. (2014). Nesfatin-1: role as possible new anti-obesity treatment. EXCLI Journal, 13, 586–591. Retrieved from https://www.excli.de/index.php/excli/article/view/724

Issue

Section

Review articles

Most read articles by the same author(s)